medigraphic.com
ISSN 1405-8790 (Impreso)

2015, Número 2

<< Anterior

Rev Mex Med Fis Rehab 2015; 27 (2)


Proloterapia: agentes proliferativos en el manejo del dolor crónico de origen musculoesquelético

Coria-Serranía L, Herrera-Flores R, Villaseñor-Moreno JC, Escobar-Reyes VH, Sánchez-Ortiz ÁO

Idioma: Español
Referencias bibliográficas: 55
Paginas: 49-58
Archivo PDF: 334.91 Kb.


RESUMEN

El dolor crónico de origen musculoesquelético, es motivo de consulta de alta frecuencia en la práctica del fisiatra. La proloterapia es una herramienta médica basada en la inyección de diversos agentes proliferativos, que tiene el potencial de aumentar el arsenal terapéutico con el que contamos para el manejo del dolor crónico de origen musculoesquelético. Presentamos una revisión sobre la historia, mecanismos de acción y aplicaciones clínicas, así como la experiencia de nuestro servicio con el uso de esta terapéutica.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Villaseñor-Moreno JC, Escobar-Reyes VH, De la Lanza-Andrade LP, Guizar-Ramírez BI. Síndrome de dolor miofascial. Epidemiologia, fisiopatología, diagnóstico y tratamiento. Rev Esp Med Quir. 2013; 18: 148-157.

  2. Villaseñor-Moreno JC, Escobar-Reyes VH, Sánchez-Ortiz AO, Quintero-Gómez IJ. Dolor de miembro fantasma: fisiopatología y tratamiento. Rev Esp Med Quir. 2014; 19: 62-68.

  3. Villaseñor-Moreno JC, Sánchez-Ortiz AO, Herrera-Flores R. Plasma rico en plaquetas y tendinopatías. Rev Esp Med Quir. 2014; 19: 316-325.

  4. Distel LM, Best TM. Prolotherapy: a clinical review of its role in treating chronic musculoskeletal pain. PM R. 2011; 3 (6 Suppl 1): S78-S81.

  5. Hackett GS, Hemwall GA, Montgomery GA. Ligament and tendon relaxation treated by prolotherapy. 5th edition. Oak Park (IL): Gustav A. Hemwall; 1993.

  6. Banks AR. A rationale for prolotherapy. J Orthop Med. 1991; 13: 54-59.

  7. Rabago D, Slattengren A, Zgierska A. Prolotherapy in primary care practice. Primary Care. 2010; 37: 65-80.

  8. Maxwell NJ, Ryan MB, Taunton JE, Gillies JH, Wong AD. Sonographically guided intratendinous injection of hyperosmolar dextrose to treat chronic tendinosis of the Achilles tendon: a pilot study. AJR Am J Roentgenol. 2007; 189 (4): W215-20.

  9. DeChellis DM, Cortazzo MH. Regenerative medicine in the field of pain medicine: prolotherapy, platelet-rich plasma therapy, and stem cell therapy-Theory and evidence. Techniques in Regional Anesthesia and Pain Management. 2011; 15 (2): 74-80.

  10. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986; 29 (8): 1039-1049.

  11. Steeds CE. The anatomy and physiology of pain. Review article. Surgery (Oxford). 2013; 31 (2): 49-53.

  12. Groen GJ, Baljet B, Drukker J. Nerves and nerve plexuses of the human vertebral column. Am J Anat. 1990; 188 (3): 282-296.

  13. Shah RV, Everett CR, McKenzie-Brown AM, Sehgal N. Discography as a diagnostic test for spinal pain: a systematic and narrative review. Pain Physician. 2005; 8 (2): 187-209.

  14. Okada K, Ohtori S, Inoue G, Orita S, Eguchi Y, Nakamura J et al. Interspinous ligament lidocaine and steroid injections for the management of baastrup’s disease: a case series. Asian Spine J. 2014; 8 (3): 260-266.

  15. Harmon D, Alexiev V. Sonoanatomy and injection technique of the iliolumbar ligament. Pain Physician. 2011; 14 (5): 469-474.

  16. Doherty C, Delahunt E, Caulfield B, Hertel J, Ryan J, Bleakley C. The incidence and prevalence of ankle sprain injury: a systematic review and meta-analysis of prospective epidemiological studies. Sports Medicine. 2014; 44 (1): 123-140.

  17. Provenzano PP, Heisey D, Hayashi K, Lakes R, Vanderby R Jr. Subfailure damage in ligament: a structural and cellular evaluation. J Appl Physiol. 2002; 92 (1): 362-371.

  18. Palesy PD. Tendon and ligament insertions a possible source of musculoskeletal pain. Cranio. 1997; 15 (3): 194-202.

  19. Linetsky FS, Manchikanti L. Regenerative injection therapy for axial pain. Tech Reg Anesth Pain Manag. 2005; 9 (1): 40-49.

  20. Freeman JW, Empson YM, Ekwueme EC, Paynter DM, Brolinson PG. Effect of prolotherapy on cellular proliferation and collagen deposition in MC3T3-E1 and patellar tendon fibroblast populations. Transl Res. 2011; 158 (3): 132-139.

  21. Kjaer M, Jorgensen NR, Heinemeier K, Magnusson SP. Exercise and regulation of bone and collagen tissue biology. Prog Mol Biol Transl Sci. 2015; 135: 259-291.

  22. Jackson TP, Gaeta R. Neurolytic blocks revisited. Curr Pain Headache Rep. 2008; 12 (1): 7-13.

  23. Liu YK, Tipton CM, Matthes RD, Bedford TG, Maynard JA, Walmer HC. An in situ study of the influence of a sclerosing solution in rabbit medial collateral ligaments and its junction strength. Connect Tissue Res. 1983; 11 (2-3): 95-102.

  24. Dagenais S, Ogunseitan O, Haldeman S, Wooley JR, Newcomb RL. Side effects and adverse events related to intraligamentous injection of sclerosing solutions (prolotherapy) for back and neck pain: a survey of practitioners. Arch Phys Med Rehabil. 2006; 87 (7): 909-913.

  25. Rabago D, Best TM, Zgierska AE, Zeisig E, Ryan M, Crane D. A systematic review of four injection therapies for lateral epicondylosis: prolotherapy, polidocanol, whole blood and platelet-rich plasma. Br J Sports Med. 2009; 43 (7): 471-481.

  26. Jensen KT, Rabago DP, Best TM, Patterson JJ, Vanderby R Jr. Response of knee ligaments to prolotherapy in a rat injury model. Am J Sports Med. 2008; 36 (7): 1347-1357.

  27. Dagenais S, Haldeman S, Wooley JR. Intraligamentous injection of sclerosing solutions (prolotherapy) for spinal pain: a critical review of the literature. Spine J. 2005; 5 (3): 310-328.

  28. Colón Y. Patient education and self-advocacy: questions and responses on pain management. J Pain Palliat Care Pharmacother. 2009; 23 (1): 51-61.

  29. Klinge SA, Sawyer GA. Effectiveness and safety of topical versus oral nonsteroidal anti-inflammatory drugs: a comprehensive review. Phys Sportsmed. 2013; 41 (2): 64-74.

  30. Rahimzadeh P, Imani F, Faiz SH, Entezary SR, Nasiri AA, Ziaeefard M. Investigation the efficacy of intra-articular prolotherapy with erythropoietin and dextrose and intra-articular pulsed radiofrequency on pain level reduction and range of motion improvement in primary osteoarthritis of knee. J Res Med Sci. 2014; 19 (8): 696-702.

  31. Reeves KD, Hassanein K. Randomized prospective double-blind placebo-controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity. Altern Ther Health Med. 2000; 6 (2): 68-74, 7-80.

  32. Reeves KD, Hassanein K. Randomized, prospective, placebo-controlled double-blind study of dextrose prolotherapy for osteoarthritic thumb and finger (DIP, PIP, and trapeziometacarpal) joints: evidence of clinical efficacy. J Altern Complement Med. 2000; 6 (4): 311-320.

  33. Martel J, Dugas C, Dubois JD, Descarreaux M. A randomized controlled trial of preventive spinal manipulation with and without a home exercise program for patients with chronic neck pain. BMC Musculoskelet Disord. 2011; 12: 41.

  34. Rabago D, Kijowski R, Woods M, Patterson JJ, Mundt M, Zgierska A et al. Association between disease-specific quality of life and magnetic resonance imaging outcomes in a clinical trial of prolotherapy for knee osteoarthritis. Arch Phys Med Rehabil. 2013; 94 (11): 2075-2082.

  35. Rabago D, Patterson JJ, Mundt M, Kijowski R, Grettie J, Segal NA et al. Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial. Ann Fam Med. 2013; 11 (3): 229-237.

  36. Jahangiri A, Moghaddam FR, Najafi S. Hypertonic dextrose versus corticosteroid local injection for the treatment of osteoarthritis in the first carpometacarpal joint: a double-blind randomized clinical trial. J Orthop Sci. 2014; 19 (5): 737-743.

  37. Grote W, Delucia R, Waxman R, Zgierska A, Wilson J, Rabago D. Repair of a complete anterior cruciate tear using prolotherapy: a case report. Int Musculoskelet Med. 2009; 31 (4): 159-165.

  38. Reeves KD, Hassanein KM. Long-term effects of dextrose prolotherapy for anterior cruciate ligament laxity. Altern Ther Health Med. 2003; 9 (3): 58-62.

  39. August M, Troulis MJ, Kaban LB. Hypomobility and hypermobility disorders of the temporomandibular joint. In: Miloro M, Ghali GE, Larsen PE et al., editors. Peterson’s principles of oral and maxillofacial surgery. London: BC Decker; 2004. p. 1033-1047.

  40. Zhou H, Hu K, Ding Y. Modified dextrose prolotherapy for recurrent temporomandibular joint dislocation. Br J Oral Maxillofac Surg. 2014; 52 (1): 63-66.

  41. Ungor C, Atasoy KT, Taskesen F, Cezairli B, Dayisoylu EH, Tosun E et al. Short-term results of prolotherapy in the management of temporomandibular joint dislocation. J Craniofac Surg. 2013; 24 (2): 411-415.

  42. Refai H, Altahhan O, Elsharkawy R. The efficacy of dextrose prolotherapy for temporomandibular joint hypermobility: a preliminary prospective, randomized, double-blind, placebo-controlled clinical trial. J Oral Maxillofac Surg. 2011; 69 (12): 2962-2970.

  43. Judson CH, Wolf JM. Lateral epicondylitis: review of injection therapies. Orthop Clin North Am. 2013; 44 (4): 615-623.

  44. Jobe FW, Ciccotti MG. Lateral and medial epicondylitis of the elbow. J Am Acad Orthop Surg. 1994; 2 (1): 1-8.

  45. Carayannopoulos A, Borg-Stein J, Sokolof J, Meleger A, Rosenberg D. Prolotherapy versus corticosteroid injections for the treatment of lateral epicondylosis: a randomized controlled trial. PM R. 2011; 3 (8): 706-715.

  46. Scarpone M, Rabago DP, Zgierska A, Arbogast G, Snell E. The efficacy of prolotherapy for lateral epicondylosis: a pilot study. Clin J Sport Med. 2008; 18 (3): 248-254.

  47. Rabago D, Lee KS, Ryan M, Chourasia AO, Sesto ME, Zgierska A et al. Hypertonic dextrose and morrhuate sodium injections (prolotherapy) for lateral epicondylosis (tennis elbow): results of a single-blind, pilot-level, randomized controlled trial. Am J Phys Med Rehabil. 2013; 92 (7): 587-596.

  48. Beeson P. Plantar fasciopathy: revisiting the risk factors. Foot Ankle Surg. 2014; 20 (3): 160-165.

  49. Kim E, Lee JH. Autologous platelet-rich plasma versus dextrose prolotherapy for the treatment of chronic recalcitrant plantar fasciitis. PM R. 2014; 6 (2): 152-158.

  50. Steilen D, Hauser R, Woldin B, Sawyer S. Chronic neck pain: making the connection between capsular ligament laxity and cervical instability. Open Orthop J. 2014; 8: 326-345.

  51. Graham N, Gross AR, Carlesso LC, Santaguida PL, Macdermid JC, Walton D et al. An ICON overview on physical modalities for neck pain and associated disorders. Open Orthop J. 2013; 7: 440-460.

  52. Onyewu O, Manchikanti L, Falco FJ, Singh V, Geffert S, Helm S 2nd et al. An update of the appraisal of the accuracy and utility of cervical discography in chronic neck pain. Pain Physician. 2012; 15 (6): E777-E806.

  53. Aquino RL, Caires PM, Furtado FC, Loureiro AV, Ferreira PH, Ferreira ML. Applying joint mobilization at different cervical vertebral levels does not influence immediate pain reduction in patients with chronic neck pain: a randomized clinical trial. J Man Manip Ther. 2009; 17 (2): 95-100.

  54. Hooper RA, Frizzell JB, Faris P. Case series on chronic whiplash related neck pain treated with intraarticular zygapophysial joint regeneration injection therapy. Pain Physician. 2007; 10 (2): 313-318.

  55. Dagenais S, Yelland MJ, Del Mar C, Schoene ML. Prolotherapy injections for chronic low-back pain. Cochrane Database Syst Rev. 2007 (2): Cd004059.




2020     |     www.medigraphic.com